Arkema OTC Stock Today

ARKAY -  USA Stock  

USD 134.07  3.33  2.55%

Arkema ADR is trading at 134.07 as of the 18th of October 2021; that is 2.55 percent increase since the beginning of the trading day. The stock's open price was 130.74. Arkema ADR has about a 33 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Arkema ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of August 2021 and ending today, the 18th of October 2021. Click here to learn more.
 Market Performance
7 of 100
  Odds Of Distress
Less than 33
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. The company has 75.83 M outstanding shares. More on Arkema ADR
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Arkema ADR OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Arkema ADR's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arkema ADR or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Legal NameArkema ADR
ChairmanThierry Henaff  (View All)
Average Analyst Recommendation
Analysts covering Arkema ADR report their recommendations after researching Arkema ADR's financial statements, talking to executives and customers, or listening in on Arkema ADR's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Arkema ADR. The Arkema consensus assessment is calculated by taking the average forecast from all of the analysts covering Arkema ADR.
Strong Buy1 Opinion
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Arkema ADR's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyOvervalued
Arkema ADR [ARKAY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arkema ADR's market, we take the total number of its shares issued and multiply it by Arkema ADR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Arkema ADR classifies itself under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 75.83 M outstanding shares. Arkema ADR has accumulated about 1.49 B in cash with 1.16 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.52.
Check Arkema ADR Probability Of Bankruptcy
Arkema ADR retains a total of 75.83 Million outstanding shares. Almost 100.0 percent of Arkema ADR outstanding shares are held by regular investors with 0.0 (percent) owned by insiders and only 0.28 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Arkema Ownership Details

Arkema Stock Price Odds Analysis

What are Arkema ADR's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Arkema ADR jumping above the current price in 90 days from now is about 17.05%. The Arkema ADR probability density function shows the probability of Arkema ADR otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Arkema ADR has a beta of 0.4143. This suggests as returns on the market go up, Arkema ADR average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arkema ADR will be expected to be much smaller as well. Additionally, the company has an alpha of 0.0772, implying that it can generate a 0.0772 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 134.07HorizonTargetOdds Up 134.07 
82.76%90 days
Based on a normal probability distribution, the odds of Arkema ADR to move above the current price in 90 days from now is about 17.05 (This Arkema ADR probability density function shows the probability of Arkema OTC Stock to fall within a particular range of prices over 90 days) .

Arkema Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Arkema ADR that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arkema ADR's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arkema ADR's value.
InstituionSecurity TypeTotal SharesValue
Freedman Financial Associates IncCommon Shares63.0K
Private Capital Group LlcCommon Shares46.0K
View Arkema ADR Diagnostics

Arkema ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Arkema ADR market risk premium is the additional return an investor will receive from holding Arkema ADR long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arkema ADR. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Arkema ADR's alpha and beta are two of the key measurements used to evaluate Arkema ADR's performance over the market, the standard measures of volatility play an important role as well.

Arkema Stock Against Markets

Picking the right benchmark for Arkema ADR otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arkema ADR otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arkema ADR is critical whether you are bullish or bearish towards Arkema ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Arkema ADR without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now


Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Arkema ADR Corporate Directors

Arkema ADR corporate directors refer to members of an Arkema ADR board of directors. The board of directors generally takes responsibility for the Arkema ADR's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arkema ADR's board members must vote for the resolution. The Arkema ADR board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Patrice Breant - Director - Shareholder Employees RepresentativeProfile
Victoire Margerie - Independent DirectorProfile
Marc Pandraud - Independent DirectorProfile
Helene MoreauLeroy - Non-Executive Independent DirectorProfile
Please continue to Trending Equities. Note that the Arkema ADR information on this page should be used as a complementary analysis to other Arkema ADR's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Arkema OTC Stock analysis

When running Arkema ADR price analysis, check to measure Arkema ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema ADR is operating at the current time. Most of Arkema ADR's value examination focuses on studying past and present price action to predict the probability of Arkema ADR's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arkema ADR's price. Additionally, you may evaluate how the addition of Arkema ADR to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
The market value of Arkema ADR is measured differently than its book value, which is the value of Arkema that is recorded on the company's balance sheet. Investors also form their own opinion of Arkema ADR's value that differs from its market value or its book value, called intrinsic value, which is Arkema ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arkema ADR's market value can be influenced by many factors that don't directly affect Arkema ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arkema ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine Arkema ADR value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arkema ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.